Generic EpiPen Pricing Parity and Less than 1% Share Supports $10 Adamis (ADMP) Target Price - Maxim Group

August 29, 2016 1:04 PM

After surging 25% on Friday as investors focused on the company's PFS an alternative to EpiPen, Adamis Pharmaceuticals (NASDAQ: ADMP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found